Clinical trial
Study of the Nevisense Device to Assess Atypical Skin Lesions
NCT04705168 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT04705168 |
|---|---|
| Title | Study of the Nevisense Device to Assess Atypical Skin Lesions |
| Official title | Performance of Nevisense Electrical Impedance Spectroscopy in Patients With Multiple Nevi and Large Acquired Nevi (LAN) |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Nevus, Multiple Nevi, Large Acquired Nevi, Skin Lesion |
| Intervention type | Diagnostic Test |
| Interventions | Nevisense electrical impedance spectroscopy |
| Enrollment | 40 |
| Start date | Jan 8, 2021 |
| Primary completion | Nov 18, 2025 |
| Completion | Nov 18, 2025 |
| First posted | Jan 12, 2021 |
| Last update posted | Nov 20, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: